Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinomaEmilio Bajetta, Roberto Buzzoni, Salvatore Artale et al.|Cancer|2004Cited by 135
Gastrointestinal stromal tumors: report of an audit and review of the literatureGuido Biasco, Fabio Farinati, Daniela Velo et al.|European Journal of Cancer Prevention|2009Cited by 51